Literature DB >> 31820177

Exploiting the Diversity of Ion Channels: Modulation of Ion Channels for Therapeutic Indications.

Yani Liu1, KeWei Wang2.   

Abstract

Ion channels are macromolecular proteins that form water-filled pores in cell membranes and they are critical for a variety of physiological and pharmacological functions. Dysfunctional ion channels can cause diseases known as channelopathies. Ion channels are encoded by approximately 400 genes, representing the second largest class of proven drug targets for therapeutic areas including neuropsychiatric disorders, cardiovascular and metabolic diseases, immunological diseases, nephrological diseases, gastrointestinal diseases, pulmonary/respiratory diseases, and many cancers. With more ion channel structures are being solved and functional robust assays are being developed, there are tremendous opportunities for identifying specific modulators targeting ion channels for new therapy.

Entities:  

Keywords:  ANO1; Arrhythmia; BK; CFTR; Cancer; Channelopathy; Drug target; Epilepsy; GABA; KCNQ; Kir; Kv7; LRRC8A; Nav; Pain; TMEM16A; hERG

Year:  2019        PMID: 31820177     DOI: 10.1007/164_2019_333

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  7 in total

Review 1.  Ion Channels and Transporters as Therapeutic Agents: From Biomolecules to Supramolecular Medicinal Chemistry.

Authors:  Giacomo Picci; Silvia Marchesan; Claudia Caltagirone
Journal:  Biomedicines       Date:  2022-04-12

2.  Inhibition of Nav1.7 channel by a novel blocker QLS-81 for alleviation of neuropathic pain.

Authors:  He-Ling Niu; Ya-Ni Liu; Deng-Qi Xue; Li-Ying Dong; Hui-Jie Liu; Jing Wang; Yi-Lin Zheng; An-Ruo Zou; Li-Ming Shao; KeWei Wang
Journal:  Acta Pharmacol Sin       Date:  2021-06-08       Impact factor: 7.169

3.  Polygonogram and isobolographic analysis of interactions between various novel antiepileptic drugs in the 6-Hz corneal stimulation-induced seizure model in mice.

Authors:  Jarogniew J Luszczki; Anna Panasiuk; Mirosław Zagaja; Sławomir Karwan; Hubert Bojar; Zbigniew Plewa; Magdalena Florek-Łuszczki
Journal:  PLoS One       Date:  2020-06-01       Impact factor: 3.240

4.  TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment.

Authors:  Shuai Guo; Xue Bai; Sai Shi; Yawen Deng; Xianjiang Kang; Hailong An
Journal:  Int J Mol Sci       Date:  2021-10-10       Impact factor: 5.923

Review 5.  The Ca2+-activated chloride channel ANO1/TMEM16A: An emerging therapeutic target for epithelium-originated diseases?

Authors:  Yani Liu; Zongtao Liu; KeWei Wang
Journal:  Acta Pharm Sin B       Date:  2020-12-09       Impact factor: 11.413

Review 6.  Ion Channels and Transporters in Muscle Cell Differentiation.

Authors:  Lingye Chen; Fatemeh Hassani Nia; Tobias Stauber
Journal:  Int J Mol Sci       Date:  2021-12-19       Impact factor: 5.923

Review 7.  Ion Channels as New Attractive Targets to Improve Re-Myelination Processes in the Brain.

Authors:  Federica Cherchi; Irene Bulli; Martina Venturini; Anna Maria Pugliese; Elisabetta Coppi
Journal:  Int J Mol Sci       Date:  2021-07-06       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.